Back to Evidence
Primary experimental recordNegative / threshold

PMC10653547::ACT002612

MAP-0403_J-2

Evidence text

Paper-level observation

Table 2: KP-04, MAP-0403 J-2 MBC >512 μg/mL
tableConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antibacterial
Measure
MBC
Comparator
>
Raw observation
>512 µg/mL
Normalized measurement
>512 µg/mL
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Klebsiella pneumoniae
Assay method
Not reported by source
Sequence
KWLRRPWRRWRNH
Standardization
ready simple

Source publication

Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates.

PLOS ONE · 2023

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.